SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-21-002397
Filing Date
2021-02-17
Accepted
2021-02-17 16:03:39
Documents
16
Period of Report
2021-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp146258_8k.htm   iXBRL 8-K 37149
2 EXHIBIT 2.1 dp146258_ex0201.htm EX-2.1 560860
3 EXHIBIT 10.1 dp146258_ex1001.htm EX-10.1 78195
4 EXHIBIT 99.1 dp146258_ex9901.htm EX-99.1 28678
5 GRAPHIC image_001.jpg GRAPHIC 3655
  Complete submission text file 0000950103-21-002397.txt   1032914

Data Files

Seq Description Document Type Size
6 XBRL LABEL FILE crl-20210217_lab.xml EX-101.LAB 34592
7 XBRL PRESENTATION FILE crl-20210217_pre.xml EX-101.PRE 22706
8 XBRL SCHEMA FILE crl-20210217.xsd EX-101.SCH 3178
9 EXTRACTED XBRL INSTANCE DOCUMENT dp146258_8k_htm.xml XML 3510
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 21644686
SIC: 8731 Services-Commercial Physical & Biological Research